Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial - Publication - Bridge of Knowledge

Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial

Abstract

Citations

2 4 7

CrossRef
0

Web of Science
2 6 4

Scopus

Authors (26)

Stephan Stilgenbauer
Barbara Eichhorst
Johannes Schetelig
Peter Hillmen
John Seymour
Steven Coutre
Wojciech Jurczak MD, PhD, Prof
Stephen Mulligan
Anna Schuh
Sarit Assouline
Clemens-Martin Wendtner
Andrew Roberts
Matthew Davids
Johannes Bloehdorn
Talha Munir
Sebastian Böttcher
Lang Zhou
Ahmed Salem
Monali Desai
Brenda Chyla
Jennifer Arzt
Su Kim
Maria Verdugo
Gary Gordon
Michael Hallek
William Wierda

Cite as

Full text

full text is not available in portal

full content of the article see on external site open in new tab

Details

Category:: Magazine publication
Type:: Magazine publication
Published in:: JOURNAL OF CLINICAL ONCOLOGY no. 36, edition 19, pages 1973 - 1980,
ISSN: 0732-183X
ISSN:: 0732-183X
Publication year:: 2018
DOI:: Digital Object Identifier (open in new tab) 10.1200/jco.2017.76.6840
Verified by:: No verification

seen 130 times